Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Neurol. 2012 Aug;25(4):483-90. doi: 10.1097/WCO.0b013e3283550c22.

Update on dystonia.

Author information

1
Neurologia I, Fondazione IRCCS Istituto Neurologico Carlo Besta, Università Cattolica del Sacro Cuore, Milano, Italy. alberto.albanese@unicatt.it

Abstract

PURPOSE OF REVIEW:

This review considers the recent literature pertaining to the clinical features, genetics, neuropathology and treatment of dystonia syndromes.

RECENT FINDINGS:

The term dystonia indicates at the same time a clinical phenotype and a collection of neurological syndromes mainly of genetic origin. The physical signs contributing to the phenomenology of dystonia have been recently assembled into a coherent set. The molecular genetics of primary dystonia syndromes (DYT1 and DYT6) have been the object of extensive analysis, providing converging views on their causative mechanisms. The relationship between genotype, phenotype, and endophenotypes has been explored for hereditary and sporadic dystonia syndromes. Neurophysiological studies on DYT1 and DYT6 patients, as well as on nonmanifesting carriers, have demonstrated the presence of altered synaptic plasticity. Several recent data indicate a role of dopamine and acetylcholine (ACh) transmission in the pathophysiology of primary dystonia.

SUMMARY:

Recent findings have led to novel, testable hypotheses on cellular mechanisms and physiopathological abnormalities underlying dystonia. Neurophysiological studies, imaging data and animal models support the view that corticostriatal, cerebellar, and dopaminergic dysfunctions converge to produce the pathophysiological abnormalities of dystonia.

PMID:
22610459
DOI:
10.1097/WCO.0b013e3283550c22
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center